GLUD1 Inhibition Disrupts Glutamate Homeostasis and Induces Metabolic and Redox Stress in Gliomas
Cells · 03.08.2026 · 15 (15) · 1401
DOI: 10.3390/cells15151401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 03.08.2026. Verfasst von Malgorzata Trybula und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Division of Cell and Neurobiology, Linköping University, 581 83 Linköping, Sweden. Hauptthemen laut MEDLINE: Glioma, Glutamate Dehydrogenase, Glutamic Acid, Homeostasis. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Cancer Foundation.
Abstract (Originalsprache)
Glutamate dehydrogenase (GLUD1) links glutamine metabolism and redox regulation, yet its prognostic and functional relevance across different glioma subtypes warrants further study. Here, we show that GLUD1 expression was inversely associated with tumor grade and positively associated with survival across glioma subtypes, a relationship not fully recapitulated by broader glutaminolysis-related gene signatures. To investigate the consequences of GLUD1 inhibition, we treated endogenous IDH-mutant and IDH-wildtype glioma cell lines with the reported GLUD1 inhibitor R162. GLUD1 inhibition reduced viability in all cell lines tested. This effect was not rescued by α-ketoglutarate (α-KG) supplementation, indicating that impaired tricarboxylic acid (TCA) cycle anaplerosis was not the primary mechanism underlying GLUD1 dependency. Instead, GLUD1 inhibition caused intracellular glutamate accumulation, increased reactive oxygen species (ROS), γ-H2AX induction, and elevated intracellular calcium, while complementary in silico analyses predicted disruption of mitochondrial membrane potential following R162 exposure. Together, these findings indicate that GLUD1 inhibition induces metabolic and redox stress associated with disrupted glutamate and calcium homeostasis and DNA damage. Our findings distinguish the favorable prognostic value of GLUD1 expression from the cellular vulnerability revealed by its inhibition, supporting further investigations of GLUD1 as both a prognostic biomarker and potential therapeutic target in glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Clinical Sciences, Division of Cell and Neurobiology, Linköping University, 581 83 Linköping, Sweden.
- Clinical Genomics Linköping and Department of Biomedical and Clinical Sciences, Linköping University, 581 83 Linköping, Sweden.
- Department of Otorhinolaryngology in Linköping, Anesthetics, Operations and Specialty Surgery Center, 581 85 Linköping, Sweden.
- Faculty of Medicine, Academy of Silesia, Rolna 43, 40-555 Katowice, Poland.
- Clinical Department of Geriatrics and Palliative Medicine, 581 85 Linköping, Sweden.
- Science for Life Laboratory, Linköping University, 581 85 Linköping, Sweden.
ORCID-Profile: Małgorzata Łysiak, Emilia Wiechec, Annika Malmström, Peter Söderkvist
Förderung
- Swedish Cancer Society
- Swedish Cancer Foundation
Zitieren
APA
Trybula, M., Łysiak, M., Wiechec, E., Malmström, A., & Söderkvist, P. (2026). GLUD1 Inhibition Disrupts Glutamate Homeostasis and Induces Metabolic and Redox Stress in Gliomas. Cells, 15(15), 1401. https://doi.org/10.3390/cells15151401
Vancouver
Trybula M, Łysiak M, Wiechec E, Malmström A, Söderkvist P. GLUD1 Inhibition Disrupts Glutamate Homeostasis and Induces Metabolic and Redox Stress in Gliomas. Cells. 2026;15(15):1401. doi:10.3390/cells15151401
BibTeX
@article{Trybula2026,
author = {Trybula, Malgorzata and Łysiak, Małgorzata and Wiechec, Emilia and Malmström, Annika and Söderkvist, Peter},
title = {GLUD1 Inhibition Disrupts Glutamate Homeostasis and Induces Metabolic and Redox Stress in Gliomas},
journal = {Cells},
year = {2026},
volume = {15},
number = {15},
pages = {1401},
doi = {10.3390/cells15151401}
}
EUVIMED